TORONTO, ON / ACCESS Newswire / January 20, 2026 / NeuralCloud Solutions Inc. ("NeuralCloud"), a subsidiary of AI/ML Innovations Inc. ("AIML" or the "Company") (CSE:AIML) (OTCQB:AIMLF) (FWB:42FB), is ...
VANCOUVER, BC / ACCESS Newswire / March 21, 2025 / AI/ML Innovations Inc. ("AIML" or the "Company") (CSE:AIML)(OTCQB:AIMLF)(FWB:42FB) is pleased to announce the execution of a formal exit agreement ...
Dr. Dorian succeeds Peter Kendall, who previously served as Chair of the Medical Advisory Board. This leadership transition comes as AIML enters a phase of advanced clinical validation, regulatory ...
These patents strengthen AIML's position in the growing field of AI-assisted cardiology by protecting both the algorithmic foundations and the applied deployment stack of its technology. The dynamic ...
VANCOUVER, BC / ACCESS Newswire / September 4, 2025 / AI/ML Innovations Inc. ("AIML" or the "Company") (CSE:AIML)(OTCQB:AIMLF)(FWB:42FB) is pleased to announce that it intends to complete a ...
AI/ML Innovations Inc. operates in the digital healthcare business using artificial intelligence (AI) and machine learning (ML) in Canada. The company offers MaxYield, a device-agnostic ECG signal ...
VANCOUVER, BC / ACCESS Newswire / August 21, 2025 / AI/ML Innovations Inc. ("AIML" or the "Company") (CSE:AIML)(OTCQB:AIMLF)(FWB:42FB) is issuing the following press release to clarify its disclosure ...
Detailed price information for AI / ML Innovations Inc (AIMLF) from The Globe and Mail including charting and trades.
On October 10, 2024, AIML reported an impairment loss of $1,510,668, following an internal assessment of its investment in T2H. While T2H had achieved modest growth, AIML determined that the company ...